5 Results for "

RIPK2-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "RIPK2-IN-3" in MCE Product Catalog:

Cat. No.: HY-124643
CAS No.: 1290490-78-6
Target:  

RIP kinase

Research Areas:  

Cancer

RIPK2-IN-3 (FCG806791773) is a RIPK2 inhibitor. RIPK2-IN-3 inhibits recombinant truncated RIPK2 with an IC50 of 6.39 μM. RIPK2-IN-3 can be used for research of inflammation and cancer .
loading...
    loading...
Cat. No.: HY-122665
CAS No.: 2000209-42-5
Purity:  98.64%
Research Areas:  

Cancer

HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be uesd for breast cancer research .
loading...
    loading...
Cat. No.: HY-157456
CAS No.: 2763831-43-0
Purity:  ≥98.0%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIPK1-IN-19 is a selective RIPK1 inhibitor (IC50=15 nM). RIPK1-IN-19 does not show obvious activity against RIPK2, RIPK3, and RIPK4. RIPK1-IN-19 displays potent protective activity in TNFα-induced systemic inflammatory response syndrome (SIRS) model and Imiquimod (IMQ)-induced psoriasis model. RIPK1-IN-19 can be used in research on inflammation and immune system diseases .
loading...
    loading...
Cat. No.: HY-122665A
Purity:  98.01%
Research Areas:  

Cancer

HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 TFA also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 TFA can be uesd for breast cancer research .
loading...
    loading...
Cat. No.: HY-43784
CAS No.: 2027561-86-8
Research Areas:  

Others

RIPK2 ligand 3 is a RIPK2 ligand and can be used for the synthesis of PROTACs, such as PROTAC RIPK degrader-2 (HY-111866) .
loading...
    loading...